Gilead profit beats Street expectations on COVID and HIV sales
- ByReuters-
By Michael Erman and Sriparna Roy (Reuters) -Gilead Sciences Inc on Thursday reported a higher-than-expected fourth-quarter profit driven by strong demand for its HIV and cancer...